《美德纳Moderna（MRNA）2025年第三季度财报电话会议纪要「NASDAQ」（英文版）（26页）.pdf》由会员分享，可在线阅读，更多相关《美德纳Moderna（MRNA）2025年第三季度财报电话会议纪要「NASDAQ」（英文版）（26页）.pdf（26页珍藏版）》请在三个皮匠报告上搜索。

1、 2025 Moderna,Inc.All rights reserved.Third Quarter 2025 Financial ResultsNovember 6,2025 2025 Moderna,Inc.All rights reserved.Forward-looking statements and disclaimer2This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,as

2、 amended,including statements regarding:Modernas ability to drive use of Spikevax,mNEXSPIKE and mRESVIA;Modernas strategic global partnerships;Modernas ability to advance its pipeline to drive sales growth;Modernas 2025 financial framework;Modernas ability to deliver cost efficiencies across the bus

3、iness,improve cash costs and achieve cash breakeven in 2028;Modernas 2026 and 2027 cost framework;Modernas anticipated cost reduction drivers;Modernas ability to execute on its prioritized pipeline,including potential near-term filings and approvals;Modernas engagement with regulators,including with

4、 respect to mRNA-1083;the potential of Modernas oncology portfolio;anticipated milestones for Modernas pipeline programs;Modernas anticipated key value drivers;expectations regarding the 2025-26 COVID vaccination market,including vaccination rate;and the total addressable market for Modernas potenti

5、al products.In some cases,forward-looking statements can be identified by terminology such as“will,”“may,”“should,”“could,”“expects,”“intends,”“plans,”“aims,”“anticipates,”“believes,”“estimates,”“predicts,”“potential,”“continue,”or the negative of these terms or other comparable terminology,although

6、 not all forward-looking statements contain these words.The forward-looking statements in this presentation are neither promises nor guarantees,and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks,uncertainties,and other factors,man